Home Aminos Phenol,4-(2-aminopropyl)-

Phenol,4-(2-aminopropyl)-

CAS No.:
103-86-6
Catalog Number:
AG00859M
Molecular Formula:
C9H13NO
Molecular Weight:
151.2056
Pack Size
Purity
Availability
Location
Price(USD)
Quantity
  
250mg
95%
1 week
United States
$448
- +
Product Description
Catalog Number:
AG00859M
Chemical Name:
Phenol,4-(2-aminopropyl)-
CAS Number:
103-86-6
Molecular Formula:
C9H13NO
Molecular Weight:
151.2056
MDL Number:
MFCD00599960
IUPAC Name:
4-(2-aminopropyl)phenol
InChI:
InChI=1S/C9H13NO/c1-7(10)6-8-2-4-9(11)5-3-8/h2-5,7,11H,6,10H2,1H3
InChI Key:
GIKNHHRFLCDOEU-UHFFFAOYSA-N
SMILES:
CC(Cc1ccc(cc1)O)N
EC Number:
203-152-8
NSC Number:
170995
Properties
Complexity:
108  
Compound Is Canonicalized:
Yes
Covalently-Bonded Unit Count:
1  
Defined Atom Stereocenter Count:
0
Defined Bond Stereocenter Count:
0
Exact Mass:
151.1g/mol
Formal Charge:
0
Heavy Atom Count:
11  
Hydrogen Bond Acceptor Count:
2  
Hydrogen Bond Donor Count:
2  
Isotope Atom Count:
0
Molecular Weight:
151.209g/mol
Monoisotopic Mass:
151.1g/mol
Rotatable Bond Count:
2  
Topological Polar Surface Area:
46.2A^2
Undefined Atom Stereocenter Count:
1  
Undefined Bond Stereocenter Count:
0
XLogP3:
1.4  
Literature
Title Journal
Bladder selectivity of the novel β₃-agonist ritobegron (KUC-7483) explored by in vitro and in vivo studies in the rat. Naunyn-Schmiedeberg's archives of pharmacology 20120801
Functional investigation of β-adrenoceptors in human isolated detrusor focusing on the novel selective β3-adrenoceptor agonist KUC-7322. Naunyn-Schmiedeberg's archives of pharmacology 20120801
Effects of ritobegron (KUC-7483), a novel selective β3-adrenoceptor agonist, on bladder function in cynomolgus monkey. The Journal of pharmacology and experimental therapeutics 20120701
Opposing efficacy of group III mGlu receptor activators, LSP1-2111 and AMN082, in animal models of positive symptoms of schizophrenia. Psychopharmacology 20120401
Trace amine-associated receptor 1 is a stereoselective binding site for compounds in the amphetamine class. Bioorganic & medicinal chemistry 20111201
p-Hydroxyamphetamine causes prepulse inhibition disruption in mice: contribution of serotonin neurotransmission. Behavioural brain research 20111010
The melanin-concentrating hormone (MCH) system modulates behaviors associated with psychiatric disorders. PloS one 20110101
p-Hydroxyamphetamine causes prepulse inhibition disruptions in mice: contribution of dopamine neurotransmission. Behavioural brain research 20101225
New meconium biomarkers of prenatal methamphetamine exposure increase identification of affected neonates. Clinical chemistry 20100501
Central administration of p-hydroxyamphetamine produces a behavioral stimulant effect in rodents: evidence for the involvement of dopaminergic systems. Psychopharmacology 20100201
Current pharmacologic testing for Horner syndrome. Current neurology and neuroscience reports 20090901
Novel biomarkers of prenatal methamphetamine exposure in human meconium. Therapeutic drug monitoring 20090201
Tyramine fragment binding to BACE-1. Bioorganic & medicinal chemistry letters 20080215
Trace amine-associated receptor 1 displays species-dependent stereoselectivity for isomers of methamphetamine, amphetamine, and para-hydroxyamphetamine. The Journal of pharmacology and experimental therapeutics 20070401
Determination of amphetamine, methamphetamine, and hydroxyamphetamine derivatives in urine by gas chromatography-mass spectrometry and its relation to CYP2D6 phenotype of drug users. Journal of analytical toxicology 20070101
Cation-selective exhaustive injection and sweeping MEKC for direct analysis of methamphetamine and its metabolites in urine. Electrophoresis 20061201
A study of the metabolism of methamphetamine and 4-bromo-2,5-dimethoxyphenethylamine (2C-B) in isolated rat hepatocytes. Forensic science international 20050310
Prolactinoma presenting as painful postganglionic Horner syndrome. Neurology 20040427
The correlation of phenylephrine 1% with hydroxyamphetamine 1% in Horner's syndrome. The British journal of ophthalmology 20040401
Simultaneous determination of amphetamine derivatives in human urine after SPE extraction and HPLC-UV analysis. Biomedical chromatography : BMC 20040301
Monoamine oxidase and head-twitch response in mice. Mechanisms of alpha-methylated substrate derivatives. Neurotoxicology 20040101
Horner syndrome. Current opinion in ophthalmology 20031201
Screening for and validated quantification of amphetamines and of amphetamine- and piperazine-derived designer drugs in human blood plasma by gas chromatography/mass spectrometry. Journal of mass spectrometry : JMS 20030601
False negative hydroxyamphetamine test in horner syndrome caused by acute internal carotid artery dissection. Journal of neuro-ophthalmology : the official journal of the North American Neuro-Ophthalmology Society 20030301
The contribution of the metabolite p-hydroxyamphetamine to the central actions of p-methoxyamphetamine. Psychopharmacology 20020301
Determination of amphetamine and its metabolite p-hydroxyamphetamine in rat urine by reversed-phase high-performance liquid chromatography after dabsyl derivatization. Biomedical chromatography : BMC 20011101
Hydroxyamphetamine drops for Horner's syndrome. Canadian journal of ophthalmology. Journal canadien d'ophtalmologie 20010801
Hydroxyamphetamine increases intraocular pressure in rabbits. Archives of ophthalmology (Chicago, Ill. : 1960) 20010201
Simultaneous determination of methamphetamine and its metabolites in monkey urine by gas chromatography/mass spectrometry with selected ion monitoring. Journal of analytical toxicology 19890101
Properties